Alnylam Pharmaceuticals Inc

Visual Financials
Company Name: Alnylam Pharmaceuticals Inc
Ticker Symbol: ALNY
CIK Number: 0001178670
WWW Address: http://www.alnylam.com
CEO: Dr. John M. Maraganore,PhD
No. of Employees: 514
Common Issue Type: CS
Business Description:Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 82.07 Down -2.82 81.8 92.0 85.06 86.23 79.79 1376402
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 8,735.3 106.4 0.00 -7.57 0.00 0.0 0.0 124.22 - 60.27
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close82.07$
PE Ratio - LTM0.0
Market Capitalisation8,735.3mil
Latest Shares Outstanding106.4mil
Earnings pS (EPS)-7.57$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee70,336$
Effective Tax Rate0.0%
Float58.8mil
Float as % of Shares Outstanding0.6%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue4.30%
Research & Devlopment (R&D) as % of Revenue6.70%
Gross Profit Margin97.6%
EBITDA Margin-1079.0%
Pre-Tax Profit Margin0.0%
Assets Turnover4.2%
Return on Assets (ROA)-42.7%
Return on Equity (ROE)-49.6%
Return on Capital Invested (ROCI)-50.6%
Current Ratio6.7
Leverage Ratio (Assets/Equity)1.2
Interest Cover
Total Debt/Equity (Gearing Ratio)0.02
LT Debt/Total Capital2.0%
Working Capital pS9.59$
Cash pS0.00$
Book-Value pS12.23$
Tangible Book-Value pS12.23$
Cash Flow pS-5.59$
Free Cash Flow pS-6.85$
KEY FIGURES (LTM): Price info
Price/Book Ratio6.71
Price/Tangible Book Ratio0.00
Price/Cash Flow
Price/Free Cash Flow
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----5.5820,0583,320,897
4 Weeks96.0879.7984.520.4772,08115,441,620
13 Weeks96.0874.2983.122.1765,47148,224,693
26 Weeks96.0860.2776.6510.8840,974104,280,781
52 Weeks124.2260.2797.48-12.9835,935209,819,699
YTD96.0870.29-16.7797,81559,836,148
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
86.7788.4786.4081.6187.200.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.100.20.22
Income0.0
Dividend0.0
Capital SpendingNA
R&D-4.31NA-6.92
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-9.4-9.4-19.4
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.100.10-0.75
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio64.85
Current Ratio6.7
Quick Ratio (Acid Test)6.1
Liquidity Ratio (Cash)8.38
Receivables Turnover2.8
Average Collection Period129
Working Capital/Equity78.4
Working Capital pS9.61
Cash-Flow pS-5.59
Free Cash-Flow pS-6.85
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio-1.61
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio1.9
Total Debt/Equity (Gearing Ratio)0.02
LT Debt/Equity0.02
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities100.0
Interest Cover0.0
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio5.55
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-8.95
Enterprise Value (EV)/Free Cash Flow-10.60
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM6.71
Price/Cash Flow Ratio
Price/Free Cash Flow Ratio - LTM
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.63
Current Liabilities pS3.78
Tangible Book Value pS - LTM12.23
Book Value pS - LTM12.23
Capital Invested pS12.51
Cash pS - LTM0.00
Cash Flow pS - LTM-5.59
Free Cash Flow pS - LTM-6.85
Earnings pS (EPS)-7.57
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-920.47
Free Cash Flow Margin 5YEAR AVG-627.60
Net Profit Margin-10.4
Net Profit Margin - 5YEAR AVRG.-7.7
Equity Productivity0.06
Return on Equity (ROE)-0.5
Return on Equity (ROE) - 5YEAR AVRG.-0.4
Capital Invested Productivity0.06
Return on Capital Invested (ROCI)-0.4
Return on Capital Invested (ROCI) - 5YEAR AVRG.-0.4
Assets Productivity0.00
Return on Assets (ROA)-0.4
Return on Assets (ROA) - 5YEAR AVRG.-0.4
Gross Profit Margin97.6
Gross Profit Margin - 5YEAR AVRG.
EBITDA Margin - LTM-1079.0
EBIT Margin - LTM-1087.6
Pre-Tax Profit Margin-7.9
Pre-Tax Profit Margin - 5YEAR AVRG.-7.9
Effective Tax Rate-0.1
Effective Tax Rate - 5YEAR AVRG.-0.0
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee70,336
Net Income per Employee
Average Collection Period
Receivables Turnover2.8
Day's Inventory Turnover Ratio
Inventory Turnover0.1
Inventory/Sales32.1
Accounts Payble/Sales79.71
Assets/Revenue0.00
Net Working Capital Turnover0.07
Fixed Assets Turnover0.20
Total Assets Turnover0.0
Revenue per $ Cash0.18
Revenue per $ Plant0.23
Revenue per $ Common Equity0.06
Revenue per $ Capital Invested0.06
Selling, General & Adm/tive (SG&A) as % of Revenue429.6
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue674.7
R&D Expense as % of Revenue - 5YEAR AVRG.674.7

  
Your Recent History
NASDAQ
ALNY
Alnylam Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20190420 20:17:08